CCL5-Secreting Virtual Memory CD8+ T Cells Inversely Associate With Viral Reservoir Size in HIV‐1−Infected Individuals on Antiretroviral Therapy
Wei Hu,Yan-Jun Li,Cheng Zhen,You-Yuan Wang,Hui-Huang Huang,Jun Zou,Yan-Qing Zheng,Gui-Chan Huang,Si-Run Meng,Jie-Hua Jin,Jing Li,Ming-Ju Zhou,Yu-Long Fu,Peng Zhang,Xiao-Yu Li,Tao Yang,Xiu-Wen Wang,Xiu-Han Yang,Jin-Wen Song,Xing Fan,Yan-Mei Jiao,Ruo-Nan Xu,Ji-Yuan Zhang,Chun-Bao Zhou,Jin-Hong Yuan,Lei Huang,Ya-Qin Qin,Feng-Yao Wu,Ming Shi,Fu-Sheng Wang,Chao Zhang
DOI: https://doi.org/10.3389/fimmu.2022.897569
IF: 7.3
2022-05-26
Frontiers in Immunology
Abstract:Recent studies highlighted that CD8+ T cells are necessary for restraining reservoir in HIV-1-infected individuals who undergo antiretroviral therapy (ART), whereas the underlying cellular and molecular mechanisms remain largely unknown. Here, we enrolled 60 virologically suppressed HIV-1-infected individuals, to assess the correlations of the effector molecules and phenotypic subsets of CD8+ T cells with HIV-1 DNA and cell-associated unspliced RNA (CA usRNA). We found that the levels of HIV-1 DNA and usRNA correlated positively with the percentage of CCL4+CCL5- CD8+ central memory cells (T CM ) while negatively with CCL4-CCL5+ CD8+ terminally differentiated effector memory cells (T EMRA ). Moreover, a virtual memory CD8+ T cell (T VM ) subset was enriched in CCL4-CCL5+ T EMRA cells and phenotypically distinctive from CCL4+ T CM subset, supported by single-cell RNA-Seq data. Specifically, T VM cells showed superior cytotoxicity potentially driven by T-bet and RUNX3, while CCL4+ T CM subset displayed a suppressive phenotype dominated by JUNB and CREM. In viral inhibition assays, T VM cells inhibited HIV-1 reactivation more effectively than non-T VM CD8+ T cells, which was dependent on CCL5 secretion. Our study highlights CCL5-secreting T VM cells subset as a potential determinant of HIV-1 reservoir size. This might be helpful to design CD8+ T cell-based therapeutic strategies for cure of the disease.
immunology